WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2016101060) PREVENTION OF METASTASIS AND RECURRENCE AFTER PRIMARY CANCER TREATMENT
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2016/101060    International Application No.:    PCT/CA2015/000607
Publication Date: 30.06.2016 International Filing Date: 22.12.2015
Chapter 2 Demand Filed:    21.10.2016    
IPC:
A61K 39/395 (2006.01), A61P 35/00 (2006.01), A61P 35/04 (2006.01), C12Q 1/00 (2006.01), C12Q 1/68 (2006.01), G01N 33/48 (2006.01)
Applicants: ENCYT TECHNOLOGIES, INC, [CA/CA]; Suite 205, 201 Churchill Drive Membertou, NS, B1S 0H1 (CA)
Inventors: HARLESS, William Warren; (CA)
Agent: NORTON ROSE FULBRIGHT CANADA LLP; 1 Place Ville Marie, Suite 2500 Montreal, Quebec H3B 1R1 (CA)
Priority Data:
62/095,515 22.12.2014 US
62/180,925 17.06.2015 US
62/180,945 17.06.2015 US
62/212,368 31.08.2015 US
Title (EN) PREVENTION OF METASTASIS AND RECURRENCE AFTER PRIMARY CANCER TREATMENT
(FR) PRÉVENTION DE LA MÉTASTASE ET DE LA RÉCURRENCE APRÈS TRAITEMENT D'UN CANCER PRIMAIRE
Abstract: front page image
(EN)There is provided methods for inhibiting metastasis or recurrence of a cancer in a patient after a primary treatment of the patient, and compositions for same. The method comprises administering a therapeutically effective amount of a composition for inhibiting cancer stem cell enrichment In other embodiments, the method comprises administering a therapeutically effective amount of a cancer therapy targeted towards a population of proliferating cancer stem cells in the patient.
(FR)L'invention concerne des méthodes d'inhibition de la métastase ou la récurrence d'un cancer chez le patient après traitement primaire du patient, et les compositions associées. La méthode consiste en l'administration d'une quantité thérapeutiquement efficace d'une composition destinée à inhiber l'enrichissement en cellules souches cancéreuses. Dans d'autres modes de réalisation, la méthode consiste en l'administration au patient d'une quantité thérapeutiquement efficace d'un traitement anticancéreux ciblant une population de cellules souches cancéreuses en prolifération.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)